Panacea Biotec shares are sealed at 10% upper circuit at Rs. 127.25 on Tuesday, 28th June after their launch of Tenepan an economical product for the treatment of Type 2 Diabetes Mellitus. At around 13:11 hours IST there were no sellers available at Bombay Stock Exchange while there were pending buy orders of 57.207 shares. India's third largest biotechnology company, Panacea Biotech formulates a superior quality ant diabetic drug, TENEPAN which would cure Type 2 Diabetes